|1.||Bardin, Thomas: 5 articles (09/2011 - 12/2005)|
|2.||Richette, Pascal: 5 articles (09/2011 - 12/2005)|
|3.||Brown, Matthew A: 4 articles (01/2014 - 10/2002)|
|4.||Guerne, Pierre-André: 4 articles (03/2010 - 02/2007)|
|5.||Terkeltaub, Robert: 4 articles (01/2005 - 06/2002)|
|6.||Fuerst, M: 3 articles (06/2014 - 09/2009)|
|7.||Netter, Patrick: 3 articles (06/2011 - 10/2002)|
|8.||Williams, Charlene J: 3 articles (03/2006 - 10/2002)|
|9.||Johnson, Kristen: 3 articles (04/2005 - 04/2004)|
|10.||Guggenbuhl, Pascal: 2 articles (05/2015 - 12/2006)|
08/01/1986 - "Our study supports the effectiveness of oral colchicine as a prophylactic agent in recurring pseudogout."
12/15/2012 - "Colchicine 0.6 mg orally daily was initiated in March for the prophylaxis of pseudogout. "
07/01/1998 - "We advocate also, therapy with colchicine (1 mg/day, oral) in the prophylaxis of postoperative pseudogout."
06/01/1987 - "Prevention of acute attacks of pseudogout with oral colchicine."
08/01/1986 - "Ten patients with recurrent attacks of pseudogout were followed for 1 year before and 1 year after receiving oral colchicine 0.6 mg BID. "
12/15/2007 - "To determine an association between magnesium (Mg) depletion and chondrocalcinosis, which has been reported but not investigated in a cross-sectional study. "
08/01/1994 - "The reduction of chondrocalcinosis, after years of magnesium supplementation in one patient, suggests that hypomagnesemia is an important factor in the pathogenesis of chondrocalcinosis in these patients."
08/01/1994 - "In one patient, most probably as a result of magnesium supplementation, a striking reduction of chondrocalcinosis was observed during a followup of 10 years. "
01/18/1992 - "A female patient aged 45 years is described with a rare form of chondrocalcinosis caused by hypomagnesaemia due to excessive renal loss of magnesium. "
09/01/1981 - "It seems likely that a genetically determined abnormality of magnesium metabolism was responsible for the occurrence of chondrocalcinosis in this patient."
|3.||Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
01/01/2013 - "Reply to the comment by Verhoeven et al. about the article "Efficacy of anakinra in articular chondrocalcinosis--report of three cases" Joint Bone Spine 2012;79:330-1."
01/01/2013 - "et al. "Efficacy of anakinra in articular chondrocalcinosis"."
05/01/2012 - "Efficacy of anakinra in articular chondrocalcinosis: report of three cases."
02/01/2008 - "Successful treatment of resistant pseudogout with anakinra."
07/01/2009 - "Anakinra is a possible alternative in the treatment and prevention of acute attacks of pseudogout in end-stage renal failure."
|4.||Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
07/01/2012 - "The use of conventional NSAIDs, radiographic progression of OA in the opposite femorotibial compartment of the knee, failure of the ACL, and aseptic loosening did not occur more frequently among patients with chondrocalcinosis. "
01/01/2009 - "A significant reduction in serum CRP levels at one week after use of nonsteroidal anti-inflammatory drugs (NSAIDs) is a good clue to differentiate pseudogout and post-infectious polyarthritis from PMR. "
01/01/2009 - "A promptly decreased serum CRP level by NSAIDs is a good clue to differentiate pseudogout and post-infectious polyarthritis from PMR. "
01/15/1994 - "In gouty attacks, clinical steps include a diagnostic work-up seeking an aetiological cause, whereas episodes of chondrocalcinosis or apatite-induced rheumatism are treated symptomatically (rest of the joint, NSAIDs, sometimes colchicine, or local infiltration of cortisone derivatives)."
12/01/1993 - "This article describes the clinical spectrum of gout and pseudogout and discusses the role of colchicine, NSAIDs, and uric acid--lowering agents in the management of different stages of gout. "
|5.||Adrenocorticotropic Hormone (ACTH)FDA Link
04/01/1994 - "ACTH is a safe and effective treatment for acute gout and pseudogout, especially in patients with multiple medical problems."
04/01/2014 - "We performed a systematic electronic search (Medline and ScienceDirect) using the keywords gout, treatment, ACTH, adrenocorticotropic hormone, and pseudogout. "
04/01/1994 - "To determine the effectiveness of adrenocorticotropic hormone (ACTH) for acute gouty arthritis and pseudogout in a population of patients with multiple coexisting medical problems. "
04/01/1994 - "The indications for using ACTH included congestive heart failure, chronic renal insufficiency, gastrointestinal bleeding, or no response to NSAID: All episodes of pseudogout resolved in an average of 4.2 days. "
|6.||Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
06/01/1997 - "triamcinolone acetonide appears to be safe, well tolerated, and effective in the treatment of pseudogout. "
06/01/1997 - "To prospectively assess the efficacy of intramuscular (i.m.) triamcinolone acetonide in the treatment of pseudogout. "
06/01/1997 - "Fourteen patients with crystal proven pseudogout presenting with an acute attack within 5 days of onset were treated with intramuscular triamcinolone acetonide 60 mg and followed for 30 days. "
06/01/1997 - "Prospective use of intramuscular triamcinolone acetonide in pseudogout."
|7.||Spironolactone (Aldactone)FDA LinkGeneric
|8.||Diclofenac (SR 38)FDA LinkGeneric
|9.||celecoxib (Celebrex)FDA Link
05/01/2015 - "Calcium pyrophosphate dehydrate (CPPD) crystal deposition disease (also known as chondrocalcinosis, CC) is a rare metabolic arthropathy mostly seen in elderly patients. "
06/01/2014 - "Histologic specimens of the clot showed calcium pyrophosphate dihydrate crystal deposits (pseudogout). "
05/01/2014 - "early specific alterations of cartilage can be shown by joint sonography and later calcium pyrophosphate crystals can be detected as cartilage calcification (chondrocalcinosis) by radiography. "
05/01/2014 - "[Chondrocalcinosis due to calcium pyrophosphate deposition (CPPD). "
01/01/2014 - "Chondrocalcinosis (CC) most commonly results from calcium pyrophosphate crystal deposition (CPPD). "
12/01/2008 - "We propose that otolaryngology units should be more aware of the unusual sequelae of pseudogout following parathyroidectomy; it can lead to a prompt referral and commencement of early treatment."
12/01/2008 - "We summarize the clinical presentation and pathophysiology of pseudogout following parathyroidectomy. "
12/01/2008 - "A more unusual metabolic sequela of a parathyroidectomy is the development of pseudogout. "
12/01/2008 - "Pseudogout: an unusual and forgotten metabolic sequela of parathyroidectomy."
06/01/1991 - "Two cases of acute pseudogout attack following parathyroidectomy."
06/01/2015 - "Because there was no long-term improvement in her clinical symptoms, she subsequently underwent arthroplasty of the right joint, with the white material clearly seen at surgery, and the biopsy examination confirmed the clinical and arthroscopic impression of pseudogout. "
02/01/2013 - "Postoperative pseudogout after total knee arthroplasty is rare. "
02/01/2013 - "Pseudogout in the early postoperative period after total knee arthroplasty."
11/01/2012 - "A case of bilateral pseudogout 8 years after initial total knee arthroplasty (TKA) is used to highlight the clinical characteristics and treatment options for this underrecognized condition. "
11/01/2012 - "Bilateral pseudogout 8 years after bilateral total knee arthroplasty."
|4.||Renal Dialysis (Hemodialysis)
01/01/1986 - "Pseudogout in a patient on renal dialysis."
02/01/1996 - "After excluding patients with known causes such as avascular necrosis, Paget's disease, neuropathic arthropathy, endocrine disorders, radiographic evidence of chondrocalcinosis, and hemodialysis, we have seen 20 such patients who are described in this report. "
07/01/1979 - "Review of wrist roentgenograms of 82 patients (mean age, 49.0 years), undergoing hemodialysis for chronic renal failure revealed three patients (a 3.7% incidence) with chondrocalcinosis. "
01/15/1994 - "Intervertebral disc calcification is primary or secondary to chondrocalcinosis, apatite deposition disease, ochronosis and hemodialysis spondylarthropathy. "
11/01/1986 - "Oxalosis secondary to end-stage renal failure in patients treated with long-term hemodialysis can present with articular manifestations that resemble those of gout, pseudogout, and apatite deposition disease. "
12/01/1999 - "Acute pseudogout following intra-articular injection of high molecular weight hyaluronic acid."
05/01/1998 - "Pseudogout following intraarticular injection of sodium hyaluronate."
10/01/1997 - "Acute attack of chondrocalcinosis after an intraarticular injection of hyaluronan."
01/01/1988 - "The effect of intra-articular injections of glycosaminoglycan polysulphate (Arteparon) on pain, joint mobility, inflammatory reactions, cartilage calcification and the urinary excretion of inorganic pyrophosphate was studied in 12 patients with chondrocalcinosis. "